南美洲和中美洲脑癌诊断市场预测至 2028 年 - COVID-19 影响和按诊断类型（影像测试、腰椎穿刺、活检、分子测试等）进行的区域分析；癌症类型（听神经瘤、星形细胞瘤、颅咽管瘤、神经节神经瘤、多形性胶质母细胞瘤、脑膜瘤、室管膜瘤等）；最终用户（医院、专科诊所、门诊手术中心等）
No. of Pages: 145 | Report Code: TIPRE00025906 | Category: Life Sciences
No. of Pages: 145 | Report Code: TIPRE00025906 | Category: Life Sciences
脑癌是由于大脑中导致肿瘤的细胞在细胞外生长而引起的。肿瘤包括原发性脑肿瘤和继发性脑肿瘤。原发性脑肿瘤在大脑中形成，不会扩散到身体其他部位，而继发性肿瘤，也称为转移瘤，是那些始于身体其他部位的癌症。脑肿瘤分为40种主要类型，进一步分为两大类，包括良性（即生长缓慢且不易扩散）和恶性（即癌变且更容易扩散）。
< p>因此，脑癌患病率的增加预计将在未来几年对脑癌诊断产生巨大需求，预计这将进一步推动脑癌诊断市场的发展。COVID？ 19日大流行对南美洲和中美洲已经负担过重且资金不足的公共医疗系统来说是一次严峻的考验。它遭受着严重的不平等。由于大量人口生活在贫困之中，南美洲和中美洲由于过度拥挤、卫生条件有限、粮食不安全和不可预测的环境条件而持续面临广泛的健康问题。资金不足的公立医院是该地区唯一的医疗服务来源。由于新冠肺炎 (COVID-1)，巴西正处于危急境地。资源缺乏给该地区带来了更多挑战，阻碍了脑癌诊断市场的增长。所有这些因素都将限制诊断产品和服务的分销和采用，从而限制市场增长。然而，随着疫苗接种继续在这些国家进行，该地区的各个市场参与者将再次开始关注脑癌诊断的开发并增加产品的分销。因此，大流行对脑癌诊断市场的影响将减弱。
南美洲和中美洲的脑癌诊断市场预计将从2021年的6970万美元增长到2028年的1.758亿美元；预计 2021 年至 2028 年复合年增长率为 14.1%。“原发性脑肿瘤”一词是指始于大脑的肿瘤。脑部和神经系统癌症是男性和女性第十大死因。在人的一生中，患这种肿瘤的几率不到 1%。大多数原发性中枢神经系统 (CNS) 恶性肿瘤是脑肿瘤，占所有病例的 85% 至 90%。脑肿瘤可能致命，严重影响生活质量，并最终改变患者及其家人的生活。此外，肿瘤的早期发现通常可以提供更多的治疗选择。先进的成像技术可以精确定位脑肿瘤的位置。诊断工具包括磁共振成像 (MRI) 和计算机断层扫描（CT 或 CAT 扫描）。术中 MRI 还可用于指导手术期间的组织活检和肿瘤切除。磁共振波谱（MRS）用于检查肿瘤的化学特征。因此，脑癌患病率的增加迫切需要脑癌诊断工具。
从诊断类型来看，影像测试细分市场在2020年南美洲和中美洲脑癌诊断市场中占据最大份额。 从癌症类型来看，多形性胶质母细胞瘤细分市场在南美洲和中美洲脑癌诊断市场中占据最大份额2020年癌症诊断市场。就最终用户而言，医院细分市场在2020年南美洲和中美洲脑癌诊断市场中占据最大份额。
准备时参考的一些主要一手和二手来源这份关于南美洲和中美洲脑癌诊断市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd. 和 Neusoft Medical Systems。
按诊断类型
按癌症类型
< ul>
由最终用户
按国家/地区
Strategic insights for South and Central America Brain Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 69.7 Million |
| Market Size by 2028 | US$ 175.8 Million |
| Global CAGR (2021 - 2028) | 14.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 诊断类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South and Central America Brain Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Brain Cancer Diagnostics Market is valued at US$ 69.7 Million in 2021, it is projected to reach US$ 175.8 Million by 2028.
As per our report South and Central America Brain Cancer Diagnostics Market, the market size is valued at US$ 69.7 Million in 2021, projecting it to reach US$ 175.8 Million by 2028. This translates to a CAGR of approximately 14.1% during the forecast period.
The South and Central America Brain Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Brain Cancer Diagnostics Market report:
The South and Central America Brain Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Brain Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Brain Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Brain Cancer Diagnostics Market
